poltixa 2,5 mg tabletki powlekane
zakłady farmaceutyczne polpharma s.a. - apixaban - tabletki powlekane - 2,5 mg
coryzalia - tabletki drażowane
boiron sa - gelsemium + pulsatilla + allium cepa 3ch + belladonna + sabadilla + kalium bichromicum - tabletki drażowane - -
libtayo
regeneron ireland designated activity company (dac) - cemiplimab - rak, płaskonabłonkowy - Środki przeciwnowotworowe - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.
roxan 10 mg tabletki powlekane
adamed pharma s.a. - rivaroxabanum - tabletki powlekane - 10 mg
roxan 20 mg tabletki powlekane
adamed pharma s.a. - rivaroxabanum - tabletki powlekane - 20 mg
roxan 15 mg tabletki powlekane
adamed pharma s.a. - rivaroxabanum - tabletki powlekane - 15 mg
rivaroxaban synoptis 20 mg tabletki powlekane
synoptis pharma sp. z o.o. - rivaroxabanum - tabletki powlekane - 20 mg
rivaroxaban synoptis 15 mg tabletki powlekane
synoptis pharma sp. z o.o. - rivaroxabanum - tabletki powlekane - 15 mg
abatixent 5 mg tabletki powlekane
sandoz gmbh - apixabanum - tabletki powlekane - 5 mg
abatixent 2,5 mg tabletki powlekane
sandoz gmbh - apixabanum - tabletki powlekane - 2,5 mg